Lifestyle Intervention in Patients With Metastatic Prostate Cancer
ConditionProstate Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorOncology Institute of Southern Switzerland
About this trial
The proposed pilot study aims at determining the feasibility of a lifestyle intervention including adherence to a personalised dietary regimen combined with regular physical activity in patients newly diagnosed with prostate cancer under androgen deprivation therapy.
Eligibility criteria
Qualifiers
Written informed consent according to ICH/GCP regulations before registration.
Age ≥ 18 years
Histology of adenocarcinoma of the prostate
Patients with PCa receiving ADT alone or ADT+NHT (abiraterone, enzalutamide, apalutamide or darolutamide)
Disqualifiers
Ongoing treatment with docetaxel, cabazitaxel, radionuclides or investigational treatments
Evidence of clinical progression or progression of disease on imaging
Bone metastases excluding the safety of physical exercise
Prior confirmed severe osteoporosis or other diseases affecting the bone with history of fractures
Trial design
Treatments tested in this trial
- Lifestyle intervention
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov